AssayIndex
Cross-section

Tirzepatide by laboratory

The same compound measured by different laboratories on different gradients. Where the medians differ, the question is whether the material differed or the method did — and for Tirzepatide, with a class minimum gradient of 25 min, the method is a live explanation.

750 recordsmedian 98.55 %spec 97.0 %
LaboratoryReportsGradientMS resolutionMedian purity %Published bias (pp)Bias-adjustedMethod suitability
Janoshik35230minHigh98.58+0.0098.58ADEQUATE
PeptideMeter14628minHigh98.41-0.0598.45ADEQUATE
Medutest8925minUnit98.48+0.0898.40ADEQUATE
Nordanalyt6335minHigh98.69+0.0298.67ADEQUATE
VendorInvestigate6032minHigh98.41-0.1198.52ADEQUATE
Kestrel4015minUnit99.09+0.2498.85BELOW CLASS MINIMUM
96.296.997.598.298.999.5100.2JanoshikJanoshik: Q1 98.13, median 98.58, Q3 98.98, n=352outlier 96.55outlier 96.57outlier 96.65outlier 96.70outlier 96.71outlier 96.84n=352PeptideMeterPeptideMeter: Q1 97.97, median 98.41, Q3 98.94, n=146n=146MedutestMedutest: Q1 98.00, median 98.48, Q3 99.11, n=89n=89VendorInvestigateVendorInvestigate: Q1 97.85, median 98.41, Q3 98.86, n=60n=60NordanalytNordanalyt: Q1 98.20, median 98.69, Q3 99.01, n=63n=63KestrelKestrel: Q1 98.42, median 99.09, Q3 99.64, n=40n=40 Purity (% area)
Figure. Tirzepatide purity by contributing laboratory. Any offset between rows has two possible sources — a real difference in the material each laboratory happened to receive, and the laboratory's own bias — and this figure cannot separate them. The paired analysis that can is on inter-lab agreement.